Literature DB >> 2943308

The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.

J K Faulkner, D McGibney, L F Chasseaud, J L Perry, I W Taylor.   

Abstract

Intravenous administration of amlodipine (single dose, 10 mg) to 12 volunteers gave a mean plasma half-life of 34 h, mean clearance of 7 ml min-1 kg-1 and a mean apparent volume of distribution of 21 l kg-1. Oral administration (single dose, 10 mg) to the same 12 volunteers gave a mean systemic availability of 64% and a mean plasma half-life of 36 h. In a second study, repeated oral administration (once daily for 14 days, 15 mg) to 28 volunteers resulted in steady state plasma drug concentration being reached after seven doses, an accumulation of approximately threefold and a mean half-life of 45 h.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943308      PMCID: PMC1401071          DOI: 10.1111/j.1365-2125.1986.tb02874.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  45 in total

1.  Amlodipine and grapefruit juice.

Authors:  M Josefsson; J Ahlner
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

Review 2.  Amlodipine fatality in an infant with postmortem blood levels.

Authors:  Henry A Spiller; Beth A Milliner; George M Bosse
Journal:  J Med Toxicol       Date:  2012-06

Review 3.  Pharmacokinetics of newer drugs in patients with renal impairment (Part II).

Authors:  E Singlas; J P Fillastre
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

4.  BJCP 40th anniversary: moving forward, looking back.

Authors:  Annette Gilchrist; Yoon K Loke; Andrew A Somogyi; Adam F Cohen; James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

5.  The hemodynamic properties of amlodipine in anesthetised and conscious dogs: comparison with nitrendipine and influence of beta-adrenergic blockade.

Authors:  M G Dodd; D G Gardiner; A J Carter; M R Sutton; R A Burges
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

6.  Random sparse sampling strategy using stochastic simulation and estimation for a population pharmacokinetic study.

Authors:  Xiao-Hui Huang; Kun Wang; Ji-Han Huang; Ling Xu; Lu-Jin Li; Yu-Cheng Sheng; Qing-Shan Zheng
Journal:  Saudi Pharm J       Date:  2013-02-10       Impact factor: 4.330

Review 7.  Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 8.  Clinical pharmacokinetics of calcium antagonists. An update.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

9.  Once daily amlodipine in the treatment of mild to moderate hypertension.

Authors:  J Webster; O J Robb; T A Jeffers; A K Scott; J C Petrie; H M Towler
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

10.  Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition.

Authors:  P Minuz; P Pancera; M Ribul; F Priante; M Degan; A Campedelli; E Arosio; A Lechi
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.